Agentic AI Reshapes Drug Discovery: From Target Selection to Clinical Trials
james_y_zou · x · 2026-07-30
The American Heart Association's journal Circulation published an article exploring AI's cutting-edge applications in translational medicine.
- Core Content: Deputy Editor Matthew Steinhauser shares a framework for identifying early-stage discoveries with human relevance and discusses the shifting role of animal models.
- AI Application: The feature highlights how generative and agentic AI are reshaping the drug discovery pipeline, impacting everything from target selection to clinical trial recruitment.
More from Research
- Engineer Debunks Kimi K3 Memory Claims: Small State ≠ Flash Offload — AccBalanced · 2026-07-30
- Discussion: Why hasn't anyone built a neural network to detect AI text? Image detection has research papers — emeka_boris · 2026-07-30
- Agents still struggle with mathematical work: Codex spirals into 'proof certificates' and inventories — doodlestein · 2026-07-30
- TorchSpec Enables Disaggregated Speculative Decoding Training at Scale — zhyncs42 · 2026-07-30
- Compute Surge: 10 Major Scientific Breakthroughs AI Could Unlock by 2028 — Annual_Judge_7272 · 2026-07-30
- Inside SOTA Deep Research: Native Model Training and 150 Sub-Agents — SimonShaoleiDu · 2026-07-30